Skip to main content

Table 4 The survival data of subgroups according to inflammation response biomarkers

From: An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy

Groups Cutoff Patients 3-year OS 5-year OS P
NLR     <0.001
 <3.10 732 76.50% 66.10%  
 >3.10 220 58.40% 48.80%  
dNLR     <0.001
 <0.499 262 79.50% 62.80%  
 >0.499 690 65.30% 53.40%  
PLR     <0.001
 <170.58 738 75.00% 63.00%  
 >170.58 214 65.70% 48.80%  
LMR     <0.001
 <3.53 388 64.60% 77.60%  
 >3.53 564 54.60% 57.20%  
SII     <0.001
 <781.82 729 75.70% 61.00%  
 >781.82 233 66.90% 46.70%  
  1. NLR neutrophil to lymphocyte ratio
  2. dNLR derived neutrophil to lymphocyte ratio
  3. PLR platelet to lymphocyte ratio
  4. LMR lymphocyte to monocyte ratio
  5. SII systematic immune-inflammation index